Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jaap Goudsmit

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

HIV-1

Disorders

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Heeregrave Edwin J; Geels Mark J; Brenchley Jason M; Baan Elly; Ambrozak David R; van der Sluis Renee M; Bennemeer Rune; Douek Daniel C; Goudsmit Jaap; Pollakis Georgios; Koup Richard A; Paxton William A
Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.
Rodríguez Ariane; Mintardjo Ratna; Tax Dennis; Gillissen Gert; Custers Jerome; Pau Maria Grazia; Klap Jaco; Santra Sampa; Balachandran Harikrishnan; Letvin Norman L; Goudsmit Jaap; Radosevic Katarina
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
Barouch Dan H; Liu Jinyan; Lynch Diana M; O'Brien Kara L; La Porte Annalena; Simmons Nathaniel L; Riggs Ambryice M; Clark Sarah; Abbink Peter; Montefiori David C; Landucci Gary; Forthal Donald N; Self Steven G; Carville Angela; Mansfield Keith; Goudsmit Jaap
Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jaap Goudsmit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Heeregrave Edwin J; Geels Mark J; Brenchley Jason M; Baan Elly; Ambrozak David R; van der Sluis Renee M; Bennemeer Rune; Douek Daniel C; Goudsmit Jaap; Pollakis Georgios; Koup Richard A; Paxton William A
Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.
Virology 2009;393(1):24-32.
2009: Rodríguez Ariane; Mintardjo Ratna; Tax Dennis; Gillissen Gert; Custers Jerome; Pau Maria Grazia; Klap Jaco; Santra Sampa; Balachandran Harikrishnan; Letvin Norman L; Goudsmit Jaap; Radosevic Katarina
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
Vaccine 2009;27(44):6226-33.
2009: Barouch Dan H; Liu Jinyan; Lynch Diana M; O'Brien Kara L; La Porte Annalena; Simmons Nathaniel L; Riggs Ambryice M; Clark Sarah; Abbink Peter; Montefiori David C; Landucci Gary; Forthal Donald N; Self Steven G; Carville Angela; Mansfield Keith; Goudsmit Jaap
Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.
Journal of virology 2009;83(18):9584-90.
2009: O'Brien Kara L; Liu Jinyan; King Sharon L; Sun Ying-Hua; Schmitz Joern E; Lifton Michelle A; Hutnick Natalie A; Betts Michael R; Dubey Sheri A; Goudsmit Jaap; Shiver John W; Robertson Michael N; Casimiro Danilo R; Barouch Dan H
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.
Nature medicine 2009;15(8):873-5.
2009: Alba Raul; Bradshaw Angela C; Parker Alan L; Bhella David; Waddington Simon N; Nicklin Stuart A; van Rooijen Nico; Custers Jerome; Goudsmit Jaap; Barouch Dan H; McVey John H; Baker Andrew H
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
Blood 2009;114(5):965-71.
2009: Vogt Matthew R; Moesker Bastiaan; Goudsmit Jaap; Jongeneelen Mandy; Austin S Kyle; Oliphant Theodore; Nelson Steevenson; Pierson Theodore C; Wilschut Jan; Throsby Mark; Diamond Michael S
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
Journal of virology 2009;83(13):6494-507.
2009: Adams William C; Bond Emily; Havenga Menzo J E; Holterman Lennart; Goudsmit Jaap; Karlsson Hedestam Gunilla B; Koup Richard A; Loré Karin
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.
The Journal of general virology 2009;90(Pt 7):1600-10.
2009: Künzi Valérie; Klap Jaco M; Seiberling Michael K; Herzog Christian; Hartmann Katharina; Kürsteiner Oliver; Kompier Ronald; Grimaldi Roberto; Goudsmit Jaap
Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
Vaccine 2009;27(27):3561-7.
2009: Radosevic Katarina; Rodriguez Ariane; Lemckert Angelique; Goudsmit Jaap
Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.
Expert review of vaccines 2009;8(5):577-92.
2009: Koudstaal W; Hartgroves L; Havenga M; Legastelois I; Ophorst C; Sieuwerts M; Zuijdgeest D; Vogels R; Custers J; de Boer-Luijtze E; de Leeuw O; Cornelissen L; Goudsmit J; Barclay W
Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics.
Vaccine 2009;27(19):2588-93.
2009: Ekiert Damian C; Bhabha Gira; Elsliger Marc-André; Friesen Robert H E; Jongeneelen Mandy; Throsby Mark; Goudsmit Jaap; Wilson Ian A
Antibody recognition of a highly conserved influenza virus epitope.
Science (New York, N.Y.) 2009;324(5924):246-51.
2009: Liu Jinyan; O'Brien Kara L; Lynch Diana M; Simmons Nathaniel L; La Porte Annalena; Riggs Ambryice M; Abbink Peter; Coffey Rory T; Grandpre Lauren E; Seaman Michael S; Landucci Gary; Forthal Donald N; Montefiori David C; Carville Angela; Mansfield Keith G; Havenga Menzo J; Pau Maria G; Goudsmit Jaap; Barouch Dan H
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
Nature 2009;457(7225):87-91.
2009: Parker Alan L; Waddington Simon N; Buckley Suzanne M K; Custers Jerome; Havenga Menzo J E; van Rooijen Nico; Goudsmit Jaap; McVey John H; Nicklin Stuart A; Baker Andrew H
Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.
Journal of virology 2009;83(1):479-83.
2009: Ayele Workenesh; Assefa Tsehai; Lulseged Sileshi; Tegbaru Belete; Berhanu Hiwot; Tamene Wegene; Ahmedin Zenit; Tensai Birzaf W; Tafesse Mengistu; Goudsmit Jaap; Berkhout Ben; Paxton William A; Debaar Michel P; Messele Tsehaynesh; Pollakis Georgios
RNA Detection and Subtype C Assessment of HIV-1 in Infants with Diarrhea in Ethiopia.
The open AIDS journal 2009;3():19-23.
2008: Bakker A B H; Python C; Kissling C J; Pandya P; Marissen W E; Brink M F; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling G J; Uytdehaag F; Herzog C; Briggs D J; Rupprecht C E; Grimaldi R; Goudsmit J
First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
Vaccine 2008;26(47):5922-7.
2008: Kaufman David R; Liu Jinyan; Carville Angela; Mansfield Keith G; Havenga Menzo J E; Goudsmit Jaap; Barouch Dan H
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(6):4188-98.
2008: Radosevic Katarina; Rodriguez Ariane; Mintardjo Ratna; Tax Dennis; Bengtsson Karin Lövgren; Thompson Catherine; Zambon Maria; Weverling Gerrit Jan; Uytdehaag Fons; Goudsmit Jaap
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Vaccine 2008;26(29-30):3640-6.
2008: Kaufman David R; Goudsmit Jaap; Holterman Lennart; Ewald Bonnie A; Denholtz Matthew; Devoy Colleen; Giri Ayush; Grandpre Lauren E; Heraud Jean-Michel; Franchini Genoveffa; Seaman Michael S; Havenga Menzo J E; Barouch Dan H
Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
Journal of virology 2008;82(14):6829-37.
2008: Bart Pierre-Alexandre; Goodall Ruth; Barber Tristan; Harari Alexandre; Guimaraes-Walker Ana; Khonkarly Mona; Sheppard Neil C; Bangala Yolanda; Frachette Marie-Joelle; Wagner Ralf; Liljeström Peter; Kraehenbuhl Jean-Pierre; Girard Marc; Goudsmit Jaap; Esteban Mariano; Heeney Jonathan; Sattentau Quentin; McCormack Sheena; Babiker Abdel; Pantaleo Giuseppe; Weber Jonathan;
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
Vaccine 2008;26(25):3153-61.
2008: Shott Joseph P; McGrath Shannon M; Pau Maria Grazia; Custers Jerome H V; Ophorst Olga; Demoitié Marie-Ange; Dubois Marie-Claude; Komisar Jack; Cobb Michelle; Kester Kent E; Dubois Patrice; Cohen Joe; Goudsmit Jaap; Heppner D Gray; Stewart V Ann
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.
Vaccine 2008;26(23):2818-23.
2008: Liu Jinyan; Ewald Bonnie A; Lynch Diana M; Denholtz Matthew; Abbink Peter; Lemckert Angelique A C; Carville Angela; Mansfield Keith G; Havenga Menzo J; Goudsmit Jaap; Barouch Dan H
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys.
Journal of virology 2008;82(10):4844-52.
2008: Rodríguez Ariane; Goudsmit Jaap; Companjen Arjen; Mintardjo Ratna; Gillissen Gert; Tax Dennis; Sijtsma Jeroen; Weverling Gerrit Jan; Holterman Lennart; Lanar David E; Havenga Menzo J E; Radosevic Katarina
Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.
Infection and immunity 2008;76(4):1709-18.
2008: Magalhaes Isabelle; Sizemore Donata R; Ahmed Raija K; Mueller Stefanie; Wehlin Lena; Scanga Charles; Weichold Frank; Schirru Giulia; Pau Maria Grazia; Goudsmit Jaap; Kühlmann-Berenzon Sharon; Spångberg Mats; Andersson Jan; Gaines Hans; Thorstensson Rigmor; Skeiky Yasir A W; Sadoff Jerry; Maeurer Markus
rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.
PloS one 2008;3(11):e3790.
2007: Samina Itzchak; Havenga Menzo; Koudstaal Wouter; Khinich Yevgeny; Koldijk Martin; Malkinson Mertyn; Simanov Michael; Perl Shmuel; Gijsbers Linda; Weverling Gerrit Jan; Uytdehaag Fons; Goudsmit Jaap
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Vaccine 2007;25(49):8338-45.
2007: Vogels Ronald; Zuijdgeest David; van Meerendonk Michelle; Companjen Arjen; Gillissen Gert; Sijtsma Jeroen; Melis Irene; Holterman Lennart; Radosevic Katarina; Goudsmit Jaap; Havenga Menzo J E
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.
The Journal of general virology 2007;88(Pt 11):2915-24.
2007: Koldijk M H; Bogaards J A; Kostense S; de Vocht M; Gijsbers L; Ter Haak M; Ophorst C; Brakenhoff J P J; Weverling G J; Guichoux J Y; Uytdehaag F; Lewis J; Goudsmit J; Marzio G
A sensitive cell-based assay for the detection of residual infectious West Nile virus.
Vaccine 2007;25(39-40):6872-81.
2007: Ophorst Olga J A E; Radosevic Katarina; Klap Jaco M; Sijtsma Jeroen; Gillissen Gert; Mintardjo Ratna; van Ooij Mark J M; Holterman Lennart; Companjen Arjen; Goudsmit Jaap; Havenga Menzo J E
Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
Vaccine 2007;25(35):6501-10.
2007: Loré Karin; Adams William C; Havenga Menzo J E; Precopio Melissa L; Holterman Lennart; Goudsmit Jaap; Koup Richard A
Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1721-9.
2007: Radosevic Katarina; Wieland Catharina W; Rodriguez Ariane; Weverling Gerrit Jan; Mintardjo Ratna; Gillissen Gert; Vogels Ronald; Skeiky Yasir A W; Hone David M; Sadoff Jerald C; van der Poll Tom; Havenga Menzo; Goudsmit Jaap
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Infection and immunity 2007;75(8):4105-15.
2007: Abbink Peter; Lemckert Angelique A C; Ewald Bonnie A; Lynch Diana M; Denholtz Matthew; Smits Shirley; Holterman Lennart; Damen Irma; Vogels Ronald; Thorner Anna R; O'Brien Kara L; Carville Angela; Mansfield Keith G; Goudsmit Jaap; Havenga Menzo J E; Barouch Dan H
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
Journal of virology 2007;81(9):4654-63.
2007: Stewart V Ann; McGrath Shannon M; Dubois Patrice M; Pau Maria G; Mettens Pascal; Shott Joseph; Cobb Michelle; Burge J Robert; Larson David; Ware Lisa A; Demoitie Marie-Ange; Weverling Gerrit Jan; Bayat Babak; Custers Jerome H H V; Dubois Marie-Claude; Cohen Joe; Goudsmit Jaap; Heppner D Gray
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
Infection and immunity 2007;75(5):2283-90.
2007: Throsby Mark; Ter Meulen Jan; Geuijen Cecile; Goudsmit Jaap; de Kruif John
Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
Expert review of vaccines 2007;6(2):183-91.
2007: Bogaards Johannes Antonie; Putter Hein; Jan Weverling Gerrit; Ter Meulen Jan; Goudsmit Jaap
The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysis.
Travel medicine and infectious disease 2007;5(2):70-8.
2007: Ayele Workenesh; Schuurman Rob; Messele Tsehaynesh; Dorigo-Zetsma Wendelien; Mengistu Yohannes; Goudsmit Jaap; Paxton William A; de Baar Michel P; Pollakis Georgios
Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.
Journal of clinical microbiology 2007;45(3):891-6.
2007: Marzio G; Kerkvliet E; Bogaards J A; Koelewijn S; De Groot A; Gijsbers L; Weverling G J; Vogels R; Havenga M; Custers J; Pau M G; Guichoux J Y; Lewis J; Goudsmit J
A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.
Vaccine 2007;25(12):2228-37.
2007: Nabatov Alexey A; Masharsky Alexey E; Verevochkin Sergei V; Emelyanov Alexander V; Lukashov Vladimir V; Heimer Robert; Ryder Robert W; Goudsmit Jaap; Kozlov Andrei P
The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countries.
AIDS research and human retroviruses 2007;23(2):183-92.
2007: Ophorst Olga J A E; Radosevic Katarina; Ouwehand Krista; van Beem Wouter; Mintardjo Ratna; Sijtsma Jeroen; Kaspers Jorn; Companjen Arjen; Holterman Lennart; Goudsmit Jaap; Havenga Menzo J E
Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.
Vaccine 2007;25(8):1426-36.
2007: Brouwer E; Havenga M J; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben R C; ter Horst M; Nanda D; Dirven C; Avezaat C J; Goudsmit J; Sillevis Smitt P
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
Cancer gene therapy 2007;14(2):211-9.
2007: de Kruif John; Bakker Alexander B H; Marissen Wilfred E; Kramer R Arjen; Throsby Mark; Rupprecht Charles E; Goudsmit Jaap
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.
Annual review of medicine 2007;58():359-68.
2006: Thorner Anna R; Lemckert Angelique A C; Goudsmit Jaap; Lynch Diana M; Ewald Bonnie A; Denholtz Matthew; Havenga Menzo J E; Barouch Dan H
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.
Journal of virology 2006;80(24):12009-16.
2006: Lukashov V V; Lazovskaia N V; Karamov E V; Adema K W; Gasich E L; Baan E; Titov L P; Goudsmit J; Eremin V F
[The molecular epidemiology of HIV-1 in Belarus in (1996-2004): a predominance of subtype A variants and circulation of subtype B variants]
Voprosy virusologii 2006;51(6):22-6.
2006: Thorner Anna R; Vogels Ronald; Kaspers Jorn; Weverling Gerrit J; Holterman Lennart; Lemckert Angelique A C; Dilraj Athmanundh; McNally Lisa M; Jeena Prakash M; Jepsen Soren; Abbink Peter; Nanda Anjali; Swanson Patricia E; Bates Andrew T; O'Brien Kara L; Havenga Menzo J E; Goudsmit Jaap; Barouch Dan H
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
Journal of clinical microbiology 2006;44(10):3781-3.
2006: Lemckert Angelique A C; Grimbergen Jos; Smits Shirley; Hartkoorn Eric; Holterman Lennart; Berkhout Ben; Barouch Dan H; Vogels Ronald; Quax Paul; Goudsmit Jaap; Havenga Menzo J E
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
The Journal of general virology 2006;87(Pt 10):2891-9.
2006: de Gruijl Tanja D; Ophorst Olga J A E; Goudsmit Jaap; Verhaagh Sandra; Lougheed Sinéad M; Radosevic Katarina; Havenga Menzo J E; Scheper Rik J
Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2208-15.
2006: Havenga M; Vogels R; Zuijdgeest D; Radosevic K; Mueller S; Sieuwerts M; Weichold F; Damen I; Kaspers J; Lemckert A; van Meerendonk M; van der Vlugt R; Holterman L; Hone D; Skeiky Y; Mintardjo R; Gillissen G; Barouch D; Sadoff J; Goudsmit J
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.
The Journal of general virology 2006;87(Pt 8):2135-43.
2006: Throsby Mark; Geuijen Cecile; Goudsmit Jaap; Bakker Arjen Q; Korimbocus Jehanara; Kramer R Arjen; Clijsters-van der Horst Marieke; de Jong Maureen; Jongeneelen Mandy; Thijsse Sandra; Smit Renate; Visser Therese J; Bijl Nora; Marissen Wilfred E; Loeb Mark; Kelvin David J; Preiser Wolfgang; ter Meulen Jan; de Kruif John
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.
Journal of virology 2006;80(14):6982-92.
2006: ter Meulen Jan; van den Brink Edward N; Poon Leo L M; Marissen Wilfred E; Leung Cynthia S W; Cox Freek; Cheung Chung Y; Bakker Arjen Q; Bogaards Johannes A; van Deventer Els; Preiser Wolfgang; Doerr Hans Wilhelm; Chow Vincent T; de Kruif John; Peiris Joseph S M; Goudsmit Jaap
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
PLoS medicine 2006;3(7):e237.
2006: Sullivan Nancy J; Geisbert Thomas W; Geisbert Joan B; Shedlock Devon J; Xu Ling; Lamoreaux Laurie; Custers Jerome H H V; Popernack Paul M; Yang Zhi-Yong; Pau Maria G; Roederer Mario; Koup Richard A; Goudsmit Jaap; Jahrling Peter B; Nabel Gary J
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.
PLoS medicine 2006;3(6):e177.
2006: Roberts Diane M; Nanda Anjali; Havenga Menzo J E; Abbink Peter; Lynch Diana M; Ewald Bonnie A; Liu Jinyan; Thorner Anna R; Swanson Patricia E; Gorgone Darci A; Lifton Michelle A; Lemckert Angelique A C; Holterman Lennart; Chen Bing; Dilraj Athmanundh; Carville Angela; Mansfield Keith G; Goudsmit Jaap; Barouch Dan H
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Nature 2006;441(7090):239-43.
2006: Kapteyn Johan C; Saidi Mohammed Drissi; Dijkstra René; Kars Cennet; Tjon Joan C M S-K; Weverling G J; de Vocht Marcel L; Kompier Ronald; van Montfort Bart A; Guichoux Jean-Yves; Goudsmit Jaap; Lagerwerf Fija M
Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
Vaccine 2006;24(16):3137-44.
2006: Goudsmit Jaap; Marissen Wilfred E; Weldon William C; Niezgoda Michael; Hanlon Cathleen A; Rice Amy B; Kruif John de; Dietzschold Bernhard; Bakker Alexander B H; Rupprecht Charles E
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
The Journal of infectious diseases 2006;193(6):796-801.
2006: Verhaagh Sandra; de Jong Esmeralda; Goudsmit Jaap; Lecollinet Sylvie; Gillissen Gert; de Vries Margreet; van Leuven Kees; Que Ivo; Ouwehand Krista; Mintardjo Ratna; Weverling Gerrit Jan; Radosevic Katarina; Richardson Jennifer; Eloit Marc; Lowik Clemens; Quax Paul; Havenga Menzo
Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors.
The Journal of general virology 2006;87(Pt 2):255-65.
2006: Bogaards Johannes A; Weverling Gerrit Jan; Zwinderman Aeilko H; Bossuyt Patrick M M; Goudsmit Jaap
Plasma HIV-1 RNA to guide patient selection for antiretroviral therapy in resource-poor settings: efficiency related to active case finding.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):232-7.
2006: Geels Mark J; Jansen Christine A; Baan Elly; De Cuyper Iris M; van Schijndel Gijs J M; Schuitemaker Hanneke; Goudsmit Jaap; Pollakis Georgios; Miedema Frank; Paxton William A; van Baarle Debbie
CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
Virology 2006;345(1):209-19.
2006: Ophorst O J A E; Radosevic K; Havenga M J E; Pau M G; Holterman L; Berkhout B; Goudsmit J; Tsuji M
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
Infection and immunity 2006;74(1):313-20.
2005: Ayele Workenesh; Baar Michel P de; Goudsmit Jaap; Kliphuis Aletta; Tilahun Tesfaye; Dorigo-Zetsma Wendelien; Wolday Dawit; Abebe Almaz; Mengistu Yohannes; Pollakis Georgios
Surveillance technology for HIV-1 subtype C in Ethiopia: an env-based NASBA molecular beacon assay to discriminate between subcluster C and C'.
Journal of virological methods 2005;130(1-2):22-9.
2005: Nanda Anjali; Lynch Diana M; Goudsmit Jaap; Lemckert Angelique A C; Ewald Bonnie A; Sumida Shawn M; Truitt Diana M; Abbink Peter; Kishko Michael G; Gorgone Darci A; Lifton Michelle A; Shen Ling; Carville Angela; Mansfield Keith G; Havenga Menzo J E; Barouch Dan H
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
Journal of virology 2005;79(22):14161-8.
2005: Geels Mark J; Dubey Sheri A; Anderson Kiersten; Baan Elly; Bakker Margreet; Pollakis Georgios; Paxton William A; Shiver John W; Goudsmit Jaap
Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.
Journal of virology 2005;79(17):11247-58.
2005: Gilbert M Thomas P; Barnes Ian; Collins Matthew J; Smith Colin; Eklund Julie; Goudsmit Jaap; Poinar Hendrik; Cooper Alan
Long-term survival of ancient DNA in Egypt: response to Zink and Nerlich (2003).
American journal of physical anthropology 2005;128(1):110-4; discussion 115-8.
2005: Lemckert Angelique A C; Sumida Shawn M; Holterman Lennart; Vogels Ronald; Truitt Diana M; Lynch Diana M; Nanda Anjali; Ewald Bonnie A; Gorgone Darci A; Lifton Michelle A; Goudsmit Jaap; Havenga Menzo J E; Barouch Dan H
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.
Journal of virology 2005;79(15):9694-701.
2005: van der Kuyl Antoinette C; Polstra Abeltje M; van den Burg Remco; Jan Weverling Gerrit; Goudsmit Jaap; Cornelissen Marion
Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease.
Journal of medical virology 2005;76(4):541-6.
2005: Bakker Alexander B H; Marissen Wilfred E; Kramer R Arjen; Rice Amy B; Weldon William C; Niezgoda Michael; Hanlon Cathleen A; Thijsse Sandra; Backus Harold H J; de Kruif John; Dietzschold Bernhard; Rupprecht Charles E; Goudsmit Jaap
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Journal of virology 2005;79(14):9062-8.
2005: Geuijen Cecilia A W; Clijsters-van der Horst Marieke; Cox Freek; Rood Pauline M L; Throsby Mark; Jongeneelen Mandy A C; Backus Harold H J; van Deventer Els; Kruisbeek Ada M; Goudsmit Jaap; de Kruif John
Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery.
Journal of immunological methods 2005;302(1-2):68-77.
2005: Kramer R Arjen; Marissen Wilfred E; Goudsmit Jaap; Visser Therese J; Clijsters-Van der Horst Marieke; Bakker Arjen Q; de Jong Maureen; Jongeneelen Mandy; Thijsse Sandra; Backus Harold H J; Rice Amy B; Weldon William C; Rupprecht Charles E; Dietzschold Bernhard; Bakker Alexander B H; de Kruif John
The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.
European journal of immunology 2005;35(7):2131-45.
2005: Sumida Shawn M; Truitt Diana M; Lemckert Angelique A C; Vogels Ronald; Custers Jerome H H V; Addo Marylyn M; Lockman Shahin; Peter Trevor; Peyerl Fred W; Kishko Michael G; Jackson Shawn S; Gorgone Darci A; Lifton Michelle A; Essex Myron; Walker Bruce D; Goudsmit Jaap; Havenga Menzo J E; Barouch Dan H
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):7179-85.
2005: Bogaards Johannes A; van Ballegooijen W Marijn; Jan Weverling Gerrit; Boerlijst Maarten C; Goudsmit Jaap
Is population-level perversity a likely outcome of mass vaccination against HIV?
The Lancet infectious diseases 2005;5(5):254; author reply 255-6.
2005: Marissen Wilfred E; Kramer R Arjen; Rice Amy; Weldon William C; Niezgoda Michael; Faber Milosz; Slootstra Jerry W; Meloen Rob H; Clijsters-van der Horst Marieke; Visser Therese J; Jongeneelen Mandy; Thijsse Sandra; Throsby Mark; de Kruif John; Rupprecht Charles E; Dietzschold Bernhard; Goudsmit Jaap; Bakker Alexander B H
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.
Journal of virology 2005;79(8):4672-8.
2005: Gijsbers Linda; Koel Björn; Weggeman Miranda; Goudsmit Jaap; Havenga Menzo; Marzio Giuseppe
Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells.
Human gene therapy 2005;16(3):393-8.
2005: van den Brink Edward N; Ter Meulen Jan; Cox Freek; Jongeneelen Mandy A C; Thijsse Alexandra; Throsby Mark; Marissen Wilfred E; Rood Pauline M L; Bakker Alexander B H; Gelderblom Hans R; Martina Byron E; Osterhaus Albert D M E; Preiser Wolfgang; Doerr Hans Wilhelm; de Kruif John; Goudsmit Jaap
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
Journal of virology 2005;79(3):1635-44.
2005: Geuijen Cecilia A W; Bijl Nora; Smit Renate C M; Cox Freek; Throsby Mark; Visser Therèse J; Jongeneelen Mandy A C; Bakker Alexander B H; Kruisbeek Ada M; Goudsmit Jaap; de Kruif John
A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry.
European journal of cancer (Oxford, England : 1990) 2005;41(1):178-87.
2004: Holterman Lennart; Vogels Ronald; van der Vlugt Remko; Sieuwerts Martijn; Grimbergen Jos; Kaspers Jorn; Geelen Eric; van der Helm Esmeralda; Lemckert Angelique; Gillissen Gert; Verhaagh Sandra; Custers Jerome; Zuijdgeest David; Berkhout Ben; Bakker Margreet; Quax Paul; Goudsmit Jaap; Havenga Menzo
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
Journal of virology 2004;78(23):13207-15.
2004: Bakker Alexander B H; van den Oudenrijn Sonja; Bakker Arjen Q; Feller Nicole; van Meijer Marja; Bia Judith A; Jongeneelen Mandy A C; Visser Therese J; Bijl Nora; Geuijen Cecilia A W; Marissen Wilfred E; Radosevic Katarina; Throsby Mark; Schuurhuis Gerrit Jan; Ossenkoppele Gert J; de Kruif John; Goudsmit Jaap; Kruisbeek Ada M
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
Cancer research 2004;64(22):8443-50.
2004: Polstra Abeltje M; Cornelissen Marion; Goudsmit Jaap; van der Kuyl Antoinette C
Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Journal of medical virology 2004;74(3):390-6.
2004: Ophorst Olga J A E; Kostense Stefan; Goudsmit Jaap; De Swart Rik L; Verhaagh Sandra; Zakhartchouk Alexander; Van Meijer Marja; Sprangers Mieke; Van Amerongen Geert; Yüksel Selma; Osterhaus Albert D M E; Havenga Menzo J E
An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.
Vaccine 2004;22(23-24):3035-44.
2004: ter Meulen Jan; Bakker Alexander B H; van den Brink Edward N; Weverling Gerrit J; Martina Byron E E; Haagmans Bart L; Kuiken Thijs; de Kruif John; Preiser Wolfgang; Spaan Willy; Gelderblom Hans R; Goudsmit Jaap; Osterhaus Albert D M E
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets.
Lancet 2004;363(9427):2139-41.
2004: Murakami Pete; Havenga Menzo; Fawaz Farah; Vogels Ronald; Marzio Giuseppe; Pungor Erno; Files Jim; Do Linh; Goudsmit Jaap; McCaman Michael
Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Journal of virology 2004;78(12):6200-8.
2004: Kostense Stefan; Koudstaal Wouter; Sprangers Mieke; Weverling Gerrit Jan; Penders Germaine; Helmus Niels; Vogels Ronald; Bakker Margreet; Berkhout Ben; Havenga Menzo; Goudsmit Jaap
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector.
AIDS (London, England) 2004;18(8):1213-6.
2004: Barouch Dan H; Pau Maria G; Custers Jerome H H V; Koudstaal Wouter; Kostense Stefan; Havenga Menzo J E; Truitt Diana M; Sumida Shawn M; Kishko Michael G; Arthur Janelle C; Korioth-Schmitz Birgit; Newberg Michael H; Gorgone Darci A; Lifton Michelle A; Panicali Dennis L; Nabel Gary J; Letvin Norman L; Goudsmit Jaap
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(10):6290-7.
2004: Mercier S; Verhaagh S; Goudsmit J; Lemckert A; Monteil M; Havenga M; Eloit M
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivo.
The Journal of general virology 2004;85(Pt 5):1227-36.
2004: Ayele Workenesh; Pollakis Georgios; Abebe Almaz; Fisseha Bitew; Tegbaru Belete; Tesfaye Girma; Mengistu Yohannes; Wolday Dawit; van Gemen Bob; Goudsmit Jaap; Dorigo-Zetsma Wendelien; de Baar Michel P
Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia.
Journal of clinical microbiology 2004;42(4):1534-41.
2004: Pollakis Georgios; Abebe Almaz; Kliphuis Aletta; Chalaby Moustapha I M; Bakker Margreet; Mengistu Yohannes; Brouwer Margreet; Goudsmit Jaap; Schuitemaker Hanneke; Paxton William A
Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
Journal of virology 2004;78(6):2841-52.
2004: Sumida Shawn M; Truitt Diana M; Kishko Michael G; Arthur Janelle C; Jackson Shawn S; Gorgone Darci A; Lifton Michelle A; Koudstaal Wouter; Pau Maria G; Kostense Stefan; Havenga Menzo J E; Goudsmit Jaap; Letvin Norman L; Barouch Dan H
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.
Journal of virology 2004;78(6):2666-73.
2004: Slager Elisabeth H; van der Minne Caroline E; Goudsmit Jaap; van Oers Johanna M M; Kostense Stefan; Havenga Menzo J E; Osanto Susanne; Griffioen Marieke
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.
Cancer gene therapy 2004;11(3):227-36.
2004: Cayabyab Mark; Rohne Daniela; Pollakis Georgios; Mische Claudia; Messele Tseyanish; Abebe Almaz; Etemad-Moghadam Bijan; Yang Peter; Henson Scott; Axthelm Michael; Goudsmit Jaap; Letvin Norman L; Sodroski Joseph
Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
AIDS research and human retroviruses 2004;20(1):27-40.
2004: Reiss P; Casula M; de Ronde A; Weverling G J; Goudsmit J; Lange J M A
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
HIV medicine 2004;5(1):11-4.
2004: Lemckert Angelique A C; Goudsmit Jaap; Barouch Dan H
Challenges in the search for an HIV vaccine.
European journal of epidemiology 2004;19(6):513-6.
2003: Polstra Abeltje M; Van Den Burg Remco; Goudsmit Jaap; Cornelissen Marion
Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.
Journal of clinical microbiology 2003;41(12):5488-91.
2003: Geels Mark J; Cornelissen Marion; Schuitemaker Hanneke; Anderson Kiersten; Kwa David; Maas Jolanda; Dekker John T; Baan Elly; Zorgdrager Fokla; van den Burg Remco; van Beelen Martijn; Lukashov Vladimir V; Fu Tong-Ming; Paxton William A; van der Hoek Lia; Dubey Sheri A; Shiver John W; Goudsmit Jaap
Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.
Journal of virology 2003;77(23):12430-40.
2003: Pollakis Georgios; Abebe Almaz; Kliphuis Aletta; De Wit Tobias F Rinke; Fisseha Bitew; Tegbaru Belete; Tesfaye Girma; Negassa Hailu; Mengistu Yohannes; Fontanet Arnaud L; Cornelissen Marion; Goudsmit Jaap
Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa.
AIDS research and human retroviruses 2003;19(11):999-1008.
2003: Sprangers Mieke C; Lakhai Wandena; Koudstaal Wouter; Verhoeven Marielle; Koel Björn F; Vogels Ronald; Goudsmit Jaap; Havenga Menzo J E; Kostense Stefan
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.
Journal of clinical microbiology 2003;41(11):5046-52.
2003: Bogaards Johannes A; Goudsmit Jaap
Meeting the immense need for HAART in resource-poor settings.
The Journal of antimicrobial chemotherapy 2003;52(5):743-6.
2003: De Baar Michel P; Abebe Almaz; Kliphuis Aletta; Tesfaye Girma; Goudsmit Jaap; Pollakis Georgios
HIV type 1 C and C' subclusters based on long terminal repeat sequences in the Ethiopian type 1 subtype C epidemic.
AIDS research and human retroviruses 2003;19(10):917-22.
2003: van Ballegooijen Marijn; Bogaards Johannes A; Weverling Gerrit-Jan; Boerlijst Maarten C; Goudsmit Jaap
AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccination.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):214-20.
2003: Vogels Ronald; Zuijdgeest David; van Rijnsoever Richard; Hartkoorn Eric; Damen Irma; de Béthune Marie-Pierre; Kostense Stefan; Penders Germaine; Helmus Niels; Koudstaal Wouter; Cecchini Marco; Wetterwald Antoinette; Sprangers Mieke; Lemckert Angelique; Ophorst Olga; Koel Björn; van Meerendonk Michelle; Quax Paul; Panitti Laura; Grimbergen Jos; Bout Abraham; Goudsmit Jaap; Havenga Menzo
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.
Journal of virology 2003;77(15):8263-71.
2003: Polstra Abeltje M; Goudsmit Jaap; Cornelissen Marion
Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients.
Journal of medical virology 2003;70(4):624-7.
2003: Lonsdale R; Pau M G; Oerlemans M; Ophorst C; Vooys A; Havenga M; Goudsmit J; UytdeHaag F; Marzio G
A rapid method for immunotitration of influenza viruses using flow cytometry.
Journal of virological methods 2003;110(1):67-71.
2003: Geskus Ronald B; Miedema Frank A; Goudsmit Jaap; Reiss Peter; Schuitemaker Hanneke; Coutinho Roel A
Prediction of residual time to AIDS and death based on markers and cofactors.
Journal of acquired immune deficiency syndromes (1999) 2003;32(5):514-21.
2003: Cornelissen Marion; van der Kuyl Antoinette C; van den Burg Remco; Zorgdrager Fokla; van Noesel Carel J M; Goudsmit Jaap
Gene expression profile of AIDS-related Kaposi's sarcoma.
BMC cancer 2003;3():7.
2003: Bogaards Johannes A; Weverling Gerrit Jan; Geskus Ronald B; Miedema Frank; Lange Joep M A; Bossuyt Patrick M M; Goudsmit Jaap
Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis.
Antiviral therapy 2003;8(1):43-50.
2002: Polstra Abeltje M; Goudsmit J; Cornelissen M
Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes.
BMC infectious diseases 2002;2():18.
2002: van der Kuyl Antoinette C; van den Burg Remco; Zorgdrager Fokla; Dekker John T; Maas Jolanda; van Noesel Carel J M; Goudsmit Jaap; Cornelissen Marion
Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcoma.
BMC cancer 2002;2():21.
2002: Rinke de Wit Tobias F; Tsegaye Aster; Wolday Dawit; Hailu Binyam; Aklilu Mathias; Sanders Eduard; Hagos Measho; Kliphuis Aletta; Pollakis Georgios; Krol Anneke; Geskus Ronald; Miedema Frank; Goudsmit Jaap; Coutinho Roel; Fontanet Arnaud L
Primary HIV-1 subtype C infection in Ethiopia.
Journal of acquired immune deficiency syndromes (1999) 2002;30(5):463-70.
2002: Renwick Neil; Weverling Gerrit Jan; Brouwer Joke; Bakker Margreet; Schulz Thomas F; Goudsmit Jaap
Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma.
AIDS research and human retroviruses 2002;18(10):695-8.
2002: Renwick Neil; Dukers Nicole H T M; Weverling Gerrit Jan; Sheldon Julie A; Schulz Thomas F; Prins Maria; Coutinho Roel A; Goudsmit Jaap
Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996.
The Journal of infectious diseases 2002;185(12):1808-12.
2002: Ghani Azra C; Ferguson Neil M; Fraser Christophe; Donnelly Christl A; Danner Sven; Reiss Peter; Lange Joep; Goudsmit Jaap; Anderson Roy M; De Wolf Frank
Viral replication under combination antiretroviral therapy: a comparison of four different regimens.
Journal of acquired immune deficiency syndromes (1999) 2002;30(2):167-76.
2002: Lukashov Vladimir V; Goudsmit Jaap
Evolutionary relationships among Astroviridae.
The Journal of general virology 2002;83(Pt 6):1397-405.
2002: Chen Xianghong; Goudsmit Jaap; van der Kuyl Antoinette C
Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment.
AIDS research and human retroviruses 2002;18(8):531-4.
2002: Lukashov Vladimir V; Goudsmit Jaap
Recent evolutionary history of human immunodeficiency virus type 1 subtype B: reconstruction of epidemic onset based on sequence distances to the common ancestor.
Journal of molecular evolution 2002;54(5):680-91.
2002: Goudsmit Jaap; Bogaards Johannes A; Jurriaans Suzanne; Schuitemaker Hanneke; Lange Joep M A; Coutinho Roel A; Weverling Gerrit Jan
Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia.
AIDS (London, England) 2002;16(5):791-3.
2002: van der Kuyl Antoinette C; Ph Ballasina Donato L; Dekker John T; Maas Jolanda; Willemsen Ronald E; Goudsmit Jaap
Phylogenetic relationships among the species of the genus Testudo (Testudines: Testudinidae) inferred from mitochondrial 12S rRNA gene sequences.
Molecular phylogenetics and evolution 2002;22(2):174-83.
2001: Goudsmit J; Weverling G J; van der Hoek L; de Ronde A; Miedema F; Coutinho R A; Lange J M; Boerlijst M C
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.
AIDS (London, England) 2001;15(17):2293-301.
2001: Op de Coul E L; Coutinho R A; van der Schoot A; van Doornum G J; Lukashov V V; Goudsmit J; Cornelissen M;
The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains.
AIDS (London, England) 2001;15(17):2277-86.
2001: Ghani A C; de Wolf F; Ferguson N M; Donnelly C A; Coutinho R; Miedema F; Goudsmit J; Anderson R M
Surrogate markers for disease progression in treated HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2001;28(3):226-31.
2001: Renwick N; Weverling G J; Halaby T; Portegies P; Bakker M; Schulz T F; Goudsmit J
Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.
AIDS (London, England) 2001;15(16):2165-9.
2001: Yates S; Penning M; Goudsmit J; Frantzen I; van de Weijer B; van Strijp D; van Gemen B
Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection.
Journal of clinical microbiology 2001;39(10):3656-65.
2001: Abebe A; Lukashov V V; Pollakis G; Kliphuis A; Fontanet A L; Goudsmit J; de Wit T F
Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification.
AIDS (London, England) 2001;15(12):1555-61.
2001: Mang R; Maas J; Chen X; Goudsmit J; van Der Kuyl A C
Identification of a novel type C porcine endogenous retrovirus: evidence that copy number of endogenous retroviruses increases during host inbreeding.
The Journal of general virology 2001;82(Pt 8):1829-34.
2001: Notermans D W; de Jong J J; Goudsmit J; Bakker M; Roos M T; Nijholt L; Cremers J; Hellings J A; Danner S A; de Ronde A
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses.
AIDS research and human retroviruses 2001;17(11):1003-8.
2001: Sanders E J; de Wit T F; Fontanet A L; Goudsmit J; Miedema F; Coutinho R A
[Ethiopia-Netherlands AIDS research project]
Nederlands tijdschrift voor geneeskunde 2001;145(26):1261-5.
2001: de Wit T F; Sanders E J; Fontanet A L; Goudsmit J; Miedema F; Coutinho R A
[Results from the 'Ethiopia-Netherlands AIDS Research Project'; 1995-2000]
Nederlands tijdschrift voor geneeskunde 2001;145(26):1236-40.
2001: Lukashov V V; Huismans R; Jebbink M F; Danner S A; de Boer R J; Goudsmit J
Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
AIDS research and human retroviruses 2001;17(9):807-18.
2001: van Praag R M; Prins J M; Roos M T; Schellekens P T; Ten Berge I J; Yong S L; Schuitemaker H; Eerenberg A J; Jurriaans S; de Wolf F; Fox C H; Goudsmit J; Miedema F; Lange J M
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
Journal of clinical immunology 2001;21(3):218-26.
2001: Abebe A; Lukashov V V; Rinke De Wit T F; Fisseha B; Tegbaru B; Kliphuis A; Tesfaye G; Negassa H; Fontanet A L; Goudsmit J; Pollakis G
Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype C.
AIDS research and human retroviruses 2001;17(7):657-61.
2001: de Baar M P; Timmermans E C; Bakker M; de Rooij E; van Gemen B; Goudsmit J
One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.
Journal of clinical microbiology 2001;39(5):1895-902.
2001: Renwick N; Weverling G J; Schulz T; Goudsmit J
Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons.
The Journal of infectious diseases 2001;183(9):1427.
2001: de Baar M P; van Dooren M W; de Rooij E; Bakker M; van Gemen B; Goudsmit J; de Ronde A
Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.
Journal of clinical microbiology 2001;39(4):1378-84.
2001: Pollakis G; Kang S; Kliphuis A; Chalaby M I; Goudsmit J; Paxton W A
N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.
The Journal of biological chemistry 2001;276(16):13433-41.
2001: Lukashov V V; Goudsmit J
Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses.
Journal of virology 2001;75(6):2729-40.
2001: Dukers N H; Goudsmit J; de Wit J B; Prins M; Weverling G J; Coutinho R A
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection.
AIDS (London, England) 2001;15(3):369-78.
2001: Op de Coul E L; Prins M; Cornelissen M; van der Schoot A; Boufassa F; Brettle R P; Hernández-Aguado L; Schiffer V; McMenamin J; Rezza G; Robertson R; Zangerle R; Goudsmit J; Coutinho R A; Lukashov V V;
Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997.
AIDS (London, England) 2001;15(2):257-66.
2001: de Ronde A; van Dooren M; van Der Hoek L; Bouwhuis D; de Rooij E; van Gemen B; de Boer R; Goudsmit J
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.
Journal of virology 2001;75(2):595-602.
2000: Putter H; Prins J M; Jurriaans S; Roos M; Ferguson N M; van Praag R; van der Hoek L; Schuitemaker H; Anderson R M; Goudsmit J; Lange J M; de Wolf F
Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.
AIDS (London, England) 2000;14(18):2831-9.
2000: Gisolf E H; van Praag R M; Jurriaans S; Portegies P; Goudsmit J; Danner S A; Lange J M; Prins J M
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2000;25(5):426-33.
2000: Lukashov V V; de Ronde A; de Jong J J; Goudsmit J
Epidemiology of HIV-1 and emerging problems.
International journal of antimicrobial agents 2000;16(4):463-6.
2000: Cayabyab M; Hinuma S; Farzan M; Choe H; Fukusumi S; Kitada C; Nishizawa N; Hosoya M; Nishimura O; Messele T; Pollakis G; Goudsmit J; Fujino M; Sodroski J
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.
Journal of virology 2000;74(24):11972-6.
2000: Abebe A; Pollakis G; Fontanet A L; Fisseha B; Tegbaru B; Kliphuis A; Tesfaye G; Negassa H; Cornelissen M; Goudsmit J; Rinke de Wit T F
Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia.
AIDS research and human retroviruses 2000;16(17):1909-14.
2000: de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
AIDS (London, England) 2000;14(16):2632-3.
2000: van der Kuyl A C; van Gennep D R; Dekker J T; Goudsmit J
Routine DNA analysis based on 12S rRNA gene sequencing as a tool in the management of captive primates.
Journal of medical primatology 2000;29(5):309-17.
2000: Notermans D W; de Wolf F; Oudshoorn P; Cuijpers H T; Pirillo M; Tiller F W; McClernon D R; Prins J M; Lange J M; Danner S A; Goudsmit J; Jurriaans S
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.
AIDS research and human retroviruses 2000;16(15):1507-17.
2000: de Baar M P; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
AIDS research and human retroviruses 2000;16(14):1385-94.
2000: Holm-Hansen C; Baan E; Asjö B; Pascu F R; Goudsmit J; De Jong J J
Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.
AIDS research and human retroviruses 2000;16(9):867-70.
2000: van Baarle D; Hovenkamp E; Dukers N H; Renwick N; Kersten M J; Goudsmit J; Coutinho R A; Miedema F; van Oers M H
High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.
The Journal of infectious diseases 2000;181(6):2045-9.
2000: Op de Coul E; van der Schoot A; Goudsmit J; van den Burg R; Janssens W; Heyndrickx L; van der Groen G; Cornelissen M
Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands.
Virology 2000;270(2):267-77.
2000: Fraser C; Ferguson N M; Ghani A C; Prins J M; Lange J M; Goudsmit J; Anderson R M; de Wolf F
Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.
AIDS (London, England) 2000;14(6):659-69.
2000: Goudsmit J; Renwick N; Dukers N H; Coutinho R A; Heisterkamp S; Bakker M; Schulz T F; Cornelissen M; Weverling G J
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4838-43.
2000: De Baar M P; De Ronde A; Berkhout B; Cornelissen M; Van Der Horn K H; Van Der Schoot A M; De Wolf F; Lukashov V V; Goudsmit J
Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site.
AIDS research and human retroviruses 2000;16(5):499-504.
2000: Op De Coul E; van den Burg R; Asjö B; Goudsmit J; Cupsa A; Pascu R; Usein C; Cornelissen M
Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children.
AIDS research and human retroviruses 2000;16(4):327-36.
2000: van der Kuyl A C; Dekker J T; Goudsmit J
Primate genus Miopithecus: evidence for the existence of species and subspecies of dwarf guenons based on cellular and endogenous viral sequences.
Molecular phylogenetics and evolution 2000;14(3):403-13.
2000: Penning M; Beld M; Goudsmit J
Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA.
Virology 2000;268(1):12-6.
2000: Dukers N H; Renwick N; Prins M; Geskus R B; Schulz T F; Weverling G J; Coutinho R A; Goudsmit J
Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men.
American journal of epidemiology 2000;151(3):213-24.
2000: Cornelissen M; van Den Burg R; Zorgdrager F; Goudsmit J
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa.
The Journal of general virology 2000;81(Pt 2):515-23.
2000: Mang R; Maas J; van Der Kuyl A C; Goudsmit J
Papio cynocephalus endogenous retrovirus among old world monkeys: evidence for coevolution and ancient cross-species transmissions.
Journal of virology 2000;74(3):1578-86.
2000: Greensill J; Sheldon J A; Renwick N M; Beer B E; Norley S; Goudsmit J; Schulz T F
Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?
Journal of virology 2000;74(3):1572-7.
1999: Ferguson N M; deWolf F; Ghani A C; Fraser C; Donnelly C A; Reiss P; Lange J M; Danner S A; Garnett G P; Goudsmit J; Anderson R M
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(26):15167-72.
1999: Prins J M; Jurriaans S; van Praag R M; Blaak H; van Rij R; Schellekens P T; ten Berge I J; Yong S L; Fox C H; Roos M T; de Wolf F; Goudsmit J; Schuitemaker H; Lange J M
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
AIDS (London, England) 1999;13(17):2405-10.
1999: Lukashov V V; Huismans R; Rakhmanova A G; Lisitsina Z N; Akhtyrskaya N A; Vlasov N N; Melnick O B; Goudsmit J
Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections.
AIDS research and human retroviruses 1999;15(17):1577-83.
1999: van der Kuyl A C; Dekker J T; Goudsmit J
Discovery of a new endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant.
Journal of virology 1999;73(10):7994-8002.
1999: Notermans D W; Pakker N G; Hamann D; Foudraine N A; Kauffmann R H; Meenhorst P L; Goudsmit J; Roos M T; Schellekens P T; Miedema F; Danner S A
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
The Journal of infectious diseases 1999;180(4):1050-6.
1999: Beld M; Penning M; van Putten M; van den Hoek A; Damen M; Klein M R; Goudsmit J
Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.
Blood 1999;94(4):1183-91.
1999: Mang R; Goudsmit J; van der Kuyl A C
Novel endogenous type C retrovirus in baboons: complete sequence, providing evidence for baboon endogenous virus gag-pol ancestry.
Journal of virology 1999;73(8):7021-6.
1999: Prins J M; Sol C J; Renwick N; Goudsmit J; Veenstra J; Reiss P
Favourable effect of chemotherapy on clinical symptoms and human herpesvirus-8 DNA load in a patient with Kaposi's sarcoma presenting with fever and anemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1999;18(7):499-502.
1999: Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken C L; Pollakis G; Schuitemaker H; Fontanet A L; Rinke de Wit T F
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
AIDS (London, England) 1999;13(11):1305-11.
1999: Pontesilli O; Carotenuto P; Kerkhof-Garde S R; Roos M T; Keet I P; Coutinho R A; Goudsmit J; Miedema F
Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.
AIDS research and human retroviruses 1999;15(11):973-81.
1999: de Baar M P; van der Schoot A M; Goudsmit J; Jacobs F; Ehren R; van der Horn K H; Oudshoorn P; de Wolf F; de Ronde A
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target.
Journal of clinical microbiology 1999;37(6):1813-8.
1999: Yates S C; Hafez M; Beld M; Lukashov V V; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
The American journal of tropical medicine and hygiene 1999;60(4):714-20.
1999: Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Hepatology (Baltimore, Md.) 1999;29(4):1288-98.
1999: Boom R; Sol C; Beld M; Weel J; Goudsmit J; Wertheim-van Dillen P
Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding of bovine alpha-casein to silica particles.
Journal of clinical microbiology 1999;37(3):615-9.
1999: de Jong J J; Goudsmit J; Lukashov V V; Hillebrand M E; Baan E; Huismans R; Danner S A; ten Veen J H; de Wolf F; Jurriaans S
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs.
AIDS (London, England) 1999;13(1):75-80.
1999: de Baar M P; van der Horn K H; Goudsmit J; de Ronde A; de Wolf F
Detection of human immunodeficiency virus type 1 nucleocapsid protein p7 in vitro and in vivo.
Journal of clinical microbiology 1999;37(1):63-7.
1998: Renwick N; Halaby T; Weverling G J; Dukers N H; Simpson G R; Coutinho R A; Lange J M; Schulz T F; Goudsmit J
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
AIDS (London, England) 1998;12(18):2481-8.
1998: van Rij R P; de Roda Husman A M; Brouwer M; Goudsmit J; Coutinho R A; Schuitemaker H
Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
The Journal of infectious diseases 1998;178(6):1806-11.
1998: Goudsmit J; Lukashov V V; van Ameijden E J; Zorgdrager F; van den Burg R; Cornelissen M
Impact of sexual versus parenteral transmission events on the evolution of the gag and env genes of HIV type 1.
AIDS research and human retroviruses 1998;14(16):1483-6.
1998: van der Hoek L; Goudsmit J; Maas J; Sol C J
Human immunodeficiency virus type 1 in faeces and serum: evidence against independently evolving subpopulations.
The Journal of general virology 1998;79 ( Pt 10)():2455-9.
1998: Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
Journal of clinical microbiology 1998;36(10):3002-6.
1998: Lukashov V V; Karamov E V; Eremin V F; Titov L P; Goudsmit J
Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus.
AIDS research and human retroviruses 1998;14(14):1299-303.
1998: Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
AIDS (London, England) 1998;12(13):1591-600.
1998: Valli P J; Lukashov V V; Heeney J L; Goudsmit J
Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.
Journal of virology 1998;72(9):7494-500.
1998: Notermans D W; Goudsmit J; Danner S A; de Wolf F; Perelson A S; Mittler J
Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.
AIDS (London, England) 1998;12(12):1483-90.
1998: Weverling G J; Lange J M; Jurriaans S; Prins J M; Lukashov V V; Notermans D W; Roos M; Schuitemaker H; Hoetelmans R M; Danner S A; Goudsmit J; de Wolf F
Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
AIDS (London, England) 1998;12(11):F117-22.
1998: Op de Coul E L; Lukashov V V; van Doornum G J; Goudsmit J; Coutinho R A
Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes.
AIDS (London, England) 1998;12(10):1253-5.
1998: van Rij R P; Broersen S; Goudsmit J; Coutinho R A; Schuitemaker H
The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
AIDS (London, England) 1998;12(9):F85-90.
1998: Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
Virology 1998;244(2):504-12.
1998: Valli P J; Goudsmit J
Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling.
Journal of virology 1998;72(5):3673-83.
1998: Lukashov V V; Op de Coul E L; Coutinho R A; Goudsmit J
HIV-1 strains specific for Dutch injecting drug users in heterosexually infected individuals in The Netherlands.
AIDS (London, England) 1998;12(6):635-41.
1998: Beld M; Penning M; McMorrow M; Gorgels J; van den Hoek A; Goudsmit J
Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels.
Journal of clinical microbiology 1998;36(4):872-7.
1998: de Wolf F; de Jong J J; Hertogs K; Danner S A; Lange J M; Goudsmit J
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97]
Nederlands tijdschrift voor geneeskunde 1998;142(11):573-8.
1998: van der Hoek L; Sol C J; Maas J; Lukashov V V; Kuiken C L; Goudsmit J
Genetic differences between human immunodeficiency virus type 1 subpopulations in faeces and serum.
The Journal of general virology 1998;79 ( Pt 2)():259-67.
1998: Wit F W; Sol C J; Renwick N; Roos M T; Pals S T; van Leeuwen R; Goudsmit J; Reiss P
Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
AIDS (London, England) 1998;12(2):218-9.
1998: Notermans D W; Jurriaans S; de Wolf F; Foudraine N A; de Jong J J; Cavert W; Schuwirth C M; Kauffmann R H; Meenhorst P L; McDade H; Goodwin C; Leonard J M; Goudsmit J; Danner S A
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
AIDS (London, England) 1998;12(2):167-73.
1998: Blaak H; van't Wout A B; Brouwer M; Cornelissen M; Kootstra N A; Albrecht-van Lent N; Keet R P; Goudsmit J; Coutinho R A; Schuitemaker H
Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples.
Journal of virology 1998;72(1):218-24.
1998: Lukashov V V; Goudsmit J
HIV heterogeneity and disease progression in AIDS: a model of continuous virus adaptation.
AIDS (London, England) 1998;12 Suppl A():S43-52.
1997: de Wolf F; Spijkerman I; Schellekens P T; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
AIDS (London, England) 1997;11(15):1799-806.
1997: de Roda Husman A M; Koot M; Cornelissen M; Keet I P; Brouwer M; Broersen S M; Bakker M; Roos M T; Prins M; de Wolf F; Coutinho R A; Miedema F; Goudsmit J; Schuitemaker H
Association between CCR5 genotype and the clinical course of HIV-1 infection.
Annals of internal medicine 1997;127(10):882-90.
1997: Blaak H; de Wolf F; van 't Wout A B; Pakker N G; Bakker M; Goudsmit J; Schuitemaker H
Temporal relationship between human immunodeficiency virus type 1 RNA levels in serum and cellular infectious load in peripheral blood.
The Journal of infectious diseases 1997;176(5):1383-7.
1997: de Jong J J; Jurriaans S; Coutinho R A; de Wolf F; Goudsmit J
[Zidovudine-resistant HIV strains in untreated intravenous drug users and homosexual men in Amsterdam infected in 1996]
Nederlands tijdschrift voor geneeskunde 1997;141(42):2030-1.
1997: Spijkerman I J; Prins M; Goudsmit J; Veugelers P J; Coutinho R A; Miedema F; de Wolf F
Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
AIDS (London, England) 1997;11(11):1383-8.
1997: de Jong M D; de Boer R J; de Wolf F; Foudraine N A; Boucher C A; Goudsmit J; Lange J M
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.
AIDS (London, England) 1997;11(11):F79-84.
1997: Simonon A; Mulder-Kampinga G A; van de Perre P; Karita E; Msellati P; Kuiken C; Goudsmit J
Evolution of human immunodeficiency virus subtype A in women seroconverting post partum and in their offspring post-natally infected by ingestion of breast milk.
The Journal of general virology 1997;78 ( Pt 9)():2225-33.
1997: Frissen P H; de Wolf F; Reiss P; Bakker P J; Veenhof C H; Danner S A; Goudsmit J; Lange J M
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcoma.
The Journal of infectious diseases 1997;176(3):811-4.
1997: Keet I P; Janssen M; Veugelers P J; Miedema F; Klein M R; Goudsmit J; Coutinho R A; de Wolf F
Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.
The Journal of infectious diseases 1997;176(3):665-71.
1997: Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
Journal of virology 1997;71(9):6348-58.
1997: Lukashov V V; Goudsmit J
Evolution of the human immunodeficiency virus type 1 subtype-specific V3 domain is confined to a sequence space with a fixed distance to the subtype consensus.
Journal of virology 1997;71(9):6332-8.
1997: Abebe A; Kuiken C L; Goudsmit J; Valk M; Messele T; Sahlu T; Yeneneh H; Fontanet A; De Wolf F; Rinke De Wit T F
HIV type 1 subtype C in Addis Ababa, Ethiopia.
AIDS research and human retroviruses 1997;13(12):1071-5.
1997: Goudsmit J; de Ronde A; de Rooij E; de Boer R
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.
Journal of virology 1997;71(6):4479-84.
1997: de Wolf F; Goudsmit J
[AIDS; new developments. III. Predictive value of the quantity of HIV-RNA for the course of the HIV infection and the effect of the treatment]
Nederlands tijdschrift voor geneeskunde 1997;141(21):1043-50.
1997: Cavert W; Notermans D W; Staskus K; Wietgrefe S W; Zupancic M; Gebhard K; Henry K; Zhang Z Q; Mills R; McDade H; Schuwirth C M; Goudsmit J; Danner S A; Haase A T
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
Science (New York, N.Y.) 1997;276(5314):960-4.
1997: van der Kuyl A C; Mang R; Dekker J T; Goudsmit J
Complete nucleotide sequence of simian endogenous type D retrovirus with intact genome organization: evidence for ancestry to simian retrovirus and baboon endogenous virus.
Journal of virology 1997;71(5):3666-76.
1997: Lukashov V V; Goudsmit J
Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?
Journal of virology 1997;71(3):2023-30.
1997: Cornelissen M; Kuiken C; Zorgdrager F; Hartman S; Goudsmit J
Gross defects in the vpr and vpu genes of HIV type 1 cannot explain the differences in RNA copy number between long-term asymptomatics and progressors.
AIDS research and human retroviruses 1997;13(3):247-52.
1997: Kampinga G A; Simonon A; Van de Perre P; Karita E; Msellati P; Goudsmit J
Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C.
Virology 1997;227(1):63-76.
1996: van der Kuyl A C; Dekker J T; Goudsmit J
Baboon endogenous virus evolution and ecology.
Trends in microbiology 1996;4(11):455-9.
1996: Wolthers K C; Bea G; Wisman A; Otto S A; de Roda Husman A M; Schaft N; de Wolf F; Goudsmit J; Coutinho R A; van der Zee A G; Meyaard L; Miedema F
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.
Science (New York, N.Y.) 1996;274(5292):1543-7.
1996: De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J
V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.
AIDS research and human retroviruses 1996;12(16):1503-7.
1996: Cornelissen M; Kampinga G; Zorgdrager F; Goudsmit J
Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization.
Journal of virology 1996;70(11):8209-12.
1996: van der Hoek L; Sol C J; Snijders F; Bartelsman J F; Boom R; Goudsmit J
Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations.
The Journal of general virology 1996;77 ( Pt 10)():2415-25.
1996: Lukashov V V; Kuiken C L; Vlahov D; Coutinho R A; Goudsmit J
Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe.
AIDS research and human retroviruses 1996;12(12):1179-83.
1996: Goudsmit J; De Ronde A; Ho D D; Perelson A S
Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.
Journal of virology 1996;70(8):5662-4.
1996: Lukashov V V; Kuiken C L; Boer K; Goudsmit J
HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS-endemic regions.
AIDS research and human retroviruses 1996;12(10):951-3.
1996: Beld M; Sol C; Goudsmit J; Boom R
Fractionation of nucleic acids into single-stranded and double-stranded forms.
Nucleic acids research 1996;24(13):2618-9.
1996: Kuiken C L; Cornelissen M T; Zorgdrager F; Hartman S; Gibbs A J; Goudsmit J
Consistent risk group-associated differences in human immunodeficiency virus type 1 vpr, vpu and V3 sequences despite independent evolution.
The Journal of general virology 1996;77 ( Pt 4)():783-92.
1996: Kuiken C L; Lukashov V V; Baan E; Dekker J; Leunissen J A; Goudsmit J
Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the amsterdam population.
AIDS (London, England) 1996;10(1):31-7.
1995: van der Kuyl A C; Dekker J T; Goudsmit J
Distribution of baboon endogenous virus among species of African monkeys suggests multiple ancient cross-species transmissions in shared habitats.
Journal of virology 1995;69(12):7877-87.
1995: Lukashov V V; Kuiken C L; Goudsmit J
Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period.
Journal of virology 1995;69(11):6911-6.
1995: Cornelissen M; Hogervorst E; Zorgdrager F; Hartman S; Goudsmit J
Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.
AIDS research and human retroviruses 1995;11(10):1169-75.
1995: Hogervorst E; de Jong J; van Wijk A; Bakker M; Valk M; Nara P; Goudsmit J
Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.
Journal of virology 1995;69(10):6342-51.
1995: Veenstra J; Schuurman R; Cornelissen M; van't Wout A B; Boucher C A; Schuitemaker H; Goudsmit J; Coutinho R A
Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):556-60.
1995: van der Kuyl A C; Dekker J T; Goudsmit J
Full-length proviruses of baboon endogenous virus (BaEV) and dispersed BaEV reverse transcriptase retroelements in the genome of baboon species.
Journal of virology 1995;69(9):5917-24.
1995: Copeland K F; Hendrikx P J; Haaksma A G; Fiering S; Van Lier R; Goudsmit J; Heeney J L
Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors.
Virology 1995;209(2):633-6.
1995: van der Kuyl A C; Kuiken C L; Dekker J T; Perizonius W R; Goudsmit J
Nuclear counterparts of the cytoplasmic mitochondrial 12S rRNA gene: a problem of ancient DNA and molecular phylogenies.
Journal of molecular evolution 1995;40(6):652-7.
1995: Lukashov V V; Cornelissen M T; Goudsmit J; Papuashvilli M N; Rytik P G; Khaitov R M; Karamov E V; de Wolf F
Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
AIDS (London, England) 1995;9(5):435-9.
1995: ten Haaft P; Cornelissen M; Goudsmit J; Koornstra W; Dubbes R; Niphuis H; Peeters M; Thiriart C; Bruck C; Heeney J L
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.
The Journal of general virology 1995;76 ( Pt 4)():1015-20.
1995: Mulder-Kampinga G A; Simonon A; Kuiken C L; Dekker J; Scherpbier H J; van de Perre P; Boer K; Goudsmit J
Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child.
Journal of virology 1995;69(4):2285-96.
1995: Jurriaans S; Weverling G J; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
AIDS research and human retroviruses 1995;11(4):473-9.
1995: van der Hoek L; Boom R; Goudsmit J; Snijders F; Sol C J
Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum.
Journal of clinical microbiology 1995;33(3):581-8.
1995: van der Kuyl A C; Kuiken C L; Dekker J T; Goudsmit J
Phylogeny of African monkeys based upon mitochondrial 12S rRNA sequences.
Journal of molecular evolution 1995;40(2):173-80.
1995: Kuiken C L; Goudsmit J; Weiller G F; Armstrong J S; Hartman S; Portegies P; Dekker J; Cornelissen M
Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex.
The Journal of general virology 1995;76 ( Pt 1)():175-80.
1995: Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
Journal of medical virology 1995;45(1):91-8.
1994: Bruisten S M; Mientjes G H; van Delft P; de Wolf F; van Ameijden E J; Cornelissen M; Goudsmit J; Coutinho R A; Huisman J G
HIV-1 infection detected by polymerase chain reaction frequently precedes antibody seroconversion in drug users.
AIDS (London, England) 1994;8(12):1736-7.
1994: De Wolf F; Hogervorst E; Goudsmit J; Fenyö E M; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala S D
Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
AIDS research and human retroviruses 1994;10(11):1387-400.
1994: Jurriaans S; Van Gemen B; Weverling G J; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
Virology 1994;204(1):223-33.
1994: Copeland K F; Haaksma A G; Goudsmit J; Krammer P H; Heeney J L
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax.
AIDS research and human retroviruses 1994;10(10):1259-68.
1994: Copeland K F; Haaksma A G; Goudsmit J; Heeney J L
Calcium-mediated inhibition of phorbol ester and Tax trans-activation of the human T cell leukaemia virus type 1.
The Journal of general virology 1994;75 ( Pt 7)():1623-31.
1994: Keet I P; Krol A; Klein M R; Veugelers P; de Wit J; Roos M; Koot M; Goudsmit J; Miedema F; Coutinho R A
Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts.
The Journal of infectious diseases 1994;169(6):1236-43.
1994: Zwart G; van der Hoek L; Valk M; Cornelissen M T; Baan E; Dekker J; Koot M; Kuiken C L; Goudsmit J
Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Virology 1994;201(2):285-93.
1994: Back N K; Smit L; Hogervorst E; van Wijk A C; Goudsmit J; Tersmette M
Development and evaluation of an HIV-1 transfection-neutralization assay.
Journal of acquired immune deficiency syndromes 1994;7(6):531-8.
1994: Back N K; Smit L; De Jong J J; Keulen W; Schutten M; Goudsmit J; Tersmette M
An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.
Virology 1994;199(2):431-8.
1994: Kuiken C L; Goudsmit J
Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe.
AIDS research and human retroviruses 1994;10(3):319-20.
1994: Zwart G; Back N K; Ramautarsing C; Valk M; van der Hoek L; Goudsmit J
Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.
AIDS research and human retroviruses 1994;10(3):245-51.
1993: Copeland K F; Haaksma A G; Derse D; Goudsmit J; Heeney J L
Cytochemical analysis of human T cell leukaemia virus I LTR-regulated beta-galactosidase gene expression using a novel integrated cell system.
Journal of virological methods 1993;45(2):161-7.
1993: Back N K; Smit L; Schutten M; Nara P L; Tersmette M; Goudsmit J
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
Journal of virology 1993;67(11):6897-902.
1993: Portegies P; Godfried M H; Hintzen R Q; Stam J; van der Poll T; Bakker M; van Deventer S J; van Lier R A; Goudsmit J
Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex.
Journal of neuroimmunology 1993;48(2):241-7.
1993: Kuiken C L; Zwart G; Baan E; Coutinho R A; van den Hoek J A; Goudsmit J
Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):9061-5.
1993: Mientjes G H; van Ameijden E J; van den Hoek A J; Goudsmit J; Miedema F; Coutinho R A
Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
AIDS (London, England) 1993;7(10):1363-70.
1993: Mulder-Kampinga G A; Kuiken C; Dekker J; Scherpbier H J; Boer K; Goudsmit J
Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission.
The Journal of general virology 1993;74 ( Pt 9)():1747-56.
1993: Portegies P; Enting R H; de Gans J; Algra P R; Derix M M; Lange J M; Goudsmit J
Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
AIDS (London, England) 1993;7(5):669-75.
1993: Zwart G; Wolfs T F; Bookelman R; Hartman S; Bakker M; Boucher C A; Kuiken C; Goudsmit J
Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis.
AIDS (London, England) 1993;7(4):467-74.
1993: Lange J M; Teeuwsen V J; Boucher C A; Vahlne A; Barin F; Tjong-A-Hung S; Dekker J; Parkhede U; de Wolf F; Goudsmit J
Antigenic variation of the dominant gp41 epitope in Africa.
AIDS (London, England) 1993;7(4):461-6.
1993: Keet I P; Krijnen P; Koot M; Lange J M; Miedema F; Goudsmit J; Coutinho R A
Predictors of rapid progression to AIDS in HIV-1 seroconverters.
AIDS (London, England) 1993;7(1):51-7.
1993: Wolfs T F; Nara P L; Goudsmit J
Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
Chemical immunology 1993;56():1-33.
1992: Koken S E; van Wamel J L; Goudsmit J; Berkhout B; Geelen J L
Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs.
Virology 1992;191(2):968-72.
1992: Goudsmit J; de Wolf F
Markers for progression to AIDS during natural infection and antiviral therapy.
Pathologie-biologie 1992;39(9):873.
1992: Zwart G; Wolfs T F; Valk M; Van der Hoek L; Kuiken C L; Goudsmit J
Characterization of the specificity of the human antibody response to the V3 neutralization domain of HIV-1.
AIDS research and human retroviruses 1992;8(11):1897-908.
1992: De Jong J J; De Ronde A; Keulen W; Tersmette M; Goudsmit J
Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.
Journal of virology 1992;66(11):6777-80.
1992: Boucher C A; Lange J M; Miedema F F; Weverling G J; Koot M; Mulder J W; Goudsmit J; Kellam P; Larder B A; Tersmette M
HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
AIDS (London, England) 1992;6(11):1259-64.
1992: Kuiken C L; de Jong J J; Baan E; Keulen W; Tersmette M; Goudsmit J
Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
Journal of virology 1992;66(9):5704.
1992: Bruisten S M; Koppelman M H; Dekker J T; Bakker M; de Goede R E; Roos M T; de Wolf F; Coutinho R A; Goudsmit J; Huisman H G
Concordance of human immunodeficiency virus detection by polymerase chain reaction and by serologic assays in a Dutch cohort of seronegative homosexual men.
The Journal of infectious diseases 1992;166(3):620-2.
1992: Goudsmit J; Zwart G; Wolfs T
Assessment of HIV-1 antigenic diversification using serum as sample source.
AIDS research and human retroviruses 1992;8(8):1473.
1992: Kuiken C L; de Jong J J; Baan E; Keulen W; Tersmette M; Goudsmit J
Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
Journal of virology 1992;66(7):4622-7.
1992: Wolfs T F; Zwart G; Bakker M; Goudsmit J
HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.
Virology 1992;189(1):103-10.
1992: Jurriaans S; de Ronde A; Dekker J; Goudsmit J; Cornelissen M
Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals.
The Journal of general virology 1992;73 ( Pt 6)():1537-41.
1992: de Ronde A; Klaver B; Keulen W; Smit L; Goudsmit J
Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.
Virology 1992;188(1):391-5.
1992: Mulder J W; Frissen P H; Krijnen P; Endert E; de Wolf F; Goudsmit J; Masterson J G; Lange J M
Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men.
The Journal of infectious diseases 1992;165(3):413-8.
1992: de Jong J J; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A
Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
Journal of virology 1992;66(2):757-65.
1992: Blumberg B; Epstein L; de Ronde A; Goudsmit J
HIV1 3' ORF is open in pathological tissue and accelerates viral replication in primary lymphocytes.
Research in virology 1992;143(1):63-5.
1992: Boucher C A; O'Sullivan E; Mulder J W; Ramautarsing C; Kellam P; Darby G; Lange J M; Goudsmit J; Larder B A
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
The Journal of infectious diseases 1992;165(1):105-10.
1992: Langedijk J P; Back N K; Kinney-Thomas E; Bruck C; Francotte M; Goudsmit J; Meloen R H
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1.
Archives of virology 1992;126(1-4):129-46.
1992: Goudsmit J
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.
International reviews of immunology 1992;8(1):65-81.
1991: Wolfs T F; Zwart G; Bakker M; Valk M; Kuiken C L; Goudsmit J
Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution.
Virology 1991;185(1):195-205.
1991: Langedijk J P; Back N K; Durda P J; Goudsmit J; Meloen R H
Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1.
The Journal of general virology 1991;72 ( Pt 10)():2519-26.
1991: Teeuwsen V J; Lange J M; Keet R; Schattenkerk J K; Debouck C; van den Akker R; Goudsmit J; Osterhaus A D
Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers.
AIDS (London, England) 1991;5(8):971-9.
1991: Goudsmit J; Back N K; Nara P L
Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(10):2427-36.
1991: Mulder J W; Krijnen P; Coutinho R A; Bakker M; Goudsmit J; Lange J M
Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
Genitourinary medicine 1991;67(3):188-93.
1991: van den Hoek J A; Al E J; Huisman J G; Goudsmit J; Coutinho R A
Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
Journal of medical virology 1991;34(2):100-3.
1991: de Wolf F; Meloen R H; Bakker M; Barin F; Goudsmit J
Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
The Journal of general virology 1991;72 ( Pt 6)():1261-7.
1991: Zwart G; Langedijk H; van der Hoek L; de Jong J J; Wolfs T F; Ramautarsing C; Bakker M; de Ronde A; Goudsmit J
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.
Virology 1991;181(2):481-9.
1991: Epstein L G; Kuiken C; Blumberg B M; Hartman S; Sharer L R; Clement M; Goudsmit J
HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.
Virology 1991;180(2):583-90.
1991: Geelen J L; Goudsmit J
Virus-host interactions in human immunodeficiency virus infection.
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progrès en virologie médicale 1991;38():27-41.
1991: Back N K; Haigwood N L; de Wolf F; de Jongh B M; Goudsmit J
Antibody reactivity to deletion mutants of the HIV-1 SF2 envelope.
Intervirology 1991;32(3):160-72.
1991: Reiss P; de Wolf F; Kuiken C L; de Ronde A; Dekker J; Boucher C A; Debouck C; Lange J M; Goudsmit J
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
Journal of acquired immune deficiency syndromes 1991;4(2):165-72.
1990: Wolfs T F; de Jong J J; Van den Berg H; Tijnagel J M; Krone W J; Goudsmit J
Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(24):9938-42.
1990: Moody H M; Quaedflieg P J; Koole L H; van Genderen M H; Buck H M; Smit L; Jurriaans S; Geelen J L; Goudsmit J
Inhibition of HIV-1 infectivity by phosphate-methylated DNA: retraction.
Science (New York, N.Y.) 1990;250(4977):125-6.
1990: van den Hoek J A; van Haastrecht H J; Goudsmit J; de Wolf F; Coutinho R A
Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.
The Journal of infectious diseases 1990;162(4):823-6.
1990: Boucher C A; Tersmette M; Lange J M; Kellam P; de Goede R E; Mulder J W; Darby G; Goudsmit J; Larder B A
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy.
Lancet 1990;336(8715):585-90.
1990: Reiss P; Lange J M; Kuiken C L; Goudsmit J
Kaposi's sarcoma and AIDS.
Nature 1990;346(6287):801-2.
1990: Mulder J W; Lange J M; de Wolf F; Houweling J T; Bakker M; Coutinho R A; Goudsmit J
Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
The Netherlands journal of medicine 1990;37(1-2):4-10.
1990: van Griensven G J; de Vroome E M; de Wolf F; Goudsmit J; Roos M; Coutinho R A
Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men.
American journal of epidemiology 1990;132(2):203-10.
1990: Back N K; Thiriart C; Delers A; Ramautarsing C; Bruck C; Goudsmit J
Association of antibodies blocking HIV-1 gp 160-sCD4 attachment with virus neutralizing activity in human sera.
Journal of medical virology 1990;31(3):200-8.
1990: Goudsmit J; Geelen J; Keulen W; Notermans D; Kuiken C; Ramautarsing C; Smit L; Koole L; van Genderen M; Buck H
Characterization of the African HIV-1 isolate CBL-4 (RUT) by partial sequence analysis and virus neutralization with peptide antibody and antisense phosphate-methylated DNA.
AIDS (London, England) 1990;4(6):559-64.
1990: Mulder J W; Krijnen P; Goudsmit J; Schattenkerk J K; Reiss P; Lange J M
HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.
Genitourinary medicine 1990;66(3):138-41.
1990: Buck H M; Koole L H; van Genderen M H; Smit L; Geelen J L; Jurriaans S; Goudsmit J
Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity.
Science (New York, N.Y.) 1990;248(4952):208-12.
1990: Reiss P; Lange J M; de Ronde A; de Wolf F; Dekker J; Debouck C; Goudsmit J
Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.
Journal of medical virology 1990;30(3):163-8.
1990: Mulder J W; de Wolf F; Goudsmit J; Cload P A; Coutinho R A; Fiddian A P; Schellekens P T; van der Noordaa J; Lange J M
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Antiviral research 1990;13(3):127-38.
1990: Zwart G; de Jong J J; Wolfs T; van der Hoek L; Smit L; de Ronde A; Tersmette M; Nara P; Goudsmit J
Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB.
Lancet 1990;335(8687):474.
1990: Krone W J; Sninsky J J; Goudsmit J
Detection and characterization of HIV-1 by polymerase chain reaction.
Journal of acquired immune deficiency syndromes 1990;3(5):517-24.
1990: Reiss P; Lange J M; de Ronde A; de Wolf F; Dekker J; Danner S A; Debouck C; Goudsmit J
Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals.
Journal of acquired immune deficiency syndromes 1990;3(2):115-22.
1990: Goudsmit J; Meloen R H; Brasseur R
Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe.
Intervirology 1990;31(6):327-38.
1990: Boucher C A; Krone W J; Goudsmit J; Meloen R H; Naylor P H; Goldstein A L; Sun D K; Sarin P S
Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30.
Journal of clinical laboratory analysis 1990;4(1):43-7.
1989: Reiss P; De Ronde A; Lange J M; De Wolf F; Dekker J; Danner S A; Debouck C; Goudsmit J
Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.
AIDS research and human retroviruses 1989;5(6):621-8.
1989: Goudsmit J; Dekker J T; Boucher C A; Smit L; De Ronde A; Debouck C; Barin F
Serum reactivity to HIV-1 accessory gene products distinguishes East African from West African HIV strains as infecting agent.
AIDS research and human retroviruses 1989;5(5):475-7.
1989: Wolfs T F; Geelen J L; Schellekens H; Barin F; Dekker J T; Goudsmit J
Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection.
AIDS research and human retroviruses 1989;5(5):535-40.
1989: de Wolf F; Lange J M; Houweling J T; Mulder J W; Beemster J; Schellekens P T; Coutinho R A; van der Noordaa J; Goudsmit J
Appearance of predictors of disease progression in relation to the development of AIDS.
AIDS (London, England) 1989;3(9):563-9.
1989: Portegies P; de Gans J; Lange J M; Derix M M; Speelman H; Bakker M; Danner S A; Goudsmit J
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.
BMJ (Clinical research ed.) 1989;299(6703):819-21.
1989: Goudsmit J; Zwart G; Bakker M; Smit L; Back N; Epstein L; Kuiken C; d'Amaro J; de Wolf F
Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope.
Research in virology 1989;140(5):419-36.
1989: Goudsmit J; Bakker M; Smit L
Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.
Research in virology 1989;140(5):405-18.
1989: Boucher C A; de Jager M H; Debouck C; Epstein L G; de Wolf F; Wolfs T F; Goudsmit J
Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage.
Journal of clinical microbiology 1989;27(7):1577-81.
1989: van den Hoek J A; van Haastrecht H J; Scheeringa-Troost B; Goudsmit J; Coutinho R A
HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission.
Genitourinary medicine 1989;65(3):146-50.
1989: Meloen R H; Liskamp R M; Goudsmit J
Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity.
The Journal of general virology 1989;70 ( Pt 6)():1505-12.
1989: Tersmette M; Lange J M; de Goede R E; de Wolf F; Eeftink-Schattenkerk J K; Schellekens P T; Coutinho R A; Huisman J G; Goudsmit J; Miedema F
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
Lancet 1989;1(8645):983-5.
1989: Tersmette M; Gruters R A; de Wolf F; de Goede R E; Lange J M; Schellekens P T; Goudsmit J; Huisman H G; Miedema F
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
Journal of virology 1989;63(5):2118-25.
1989: Terpstra F G; Al B J; Roos M T; De Wolf F; Goudsmit J; Schellekens P T; Miedema F
Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection.
European journal of immunology 1989;19(4):667-73.
1989: Reiss P; de Ronde A; Lange J M; de Wolf F; Dekker J; Debouck C; Goudsmit J
Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression.
AIDS (London, England) 1989;3(4):227-33.
1989: Portegies P; Epstein L G; Hung S T; de Gans J; Goudsmit J
Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status.
Archives of neurology 1989;46(3):261-4.
1989: van Griensven G J; de Vroome E M; Tielman R A; Goudsmit J; de Wolf F; van der Noordaa J; Coutinho R A
Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men.
American journal of epidemiology 1989;129(3):596-603.
1989: Boucher C A; de Wolf F; Houweling J T; Bakker M; Dekker J; Roos M T; Coutinho R A; van der Noordaa J; Goudsmit J
Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression.
AIDS (London, England) 1989;3(2):71-6.
1989: van Griensven G J; de Vroome E M; Goudsmit J; Coutinho R A
Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men.
BMJ (Clinical research ed.) 1989;298(6668):218-21.
1989: Lange J M; de Wolf F; Mulder J W; Coutinho R A; van der Noordaa J; Goudsmit J
Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients.
The Journal of infection 1989;18 Suppl 1():85-91.
1989: Lelie P N; van der Poel C L; Reesink H W; Huisman H G; Boucher C A; Goudsmit J
Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection.
Vox sanguinis 1989;56(1):59-61.
1989: Lange J M; de Wolf F; Goudsmit J
Markers for progression in HIV infection.
AIDS (London, England) 1989;3 Suppl 1():S153-60.
1989: Wolfs T F; de Wolf F; Breederveld C; Sjamsjoedin-Visser L J; Roos M; Bakker M; Goudsmit J
Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: a correlate of HIV antigenaemia frequencies.
Vox sanguinis 1989;57(2):127-32.
1989: Goudsmit J; Kuiken C L; Nara P L
Linear versus conformational variation of V3 neutralization domains of HIV-1 during experimental and natural infection.
AIDS (London, England) 1989;3 Suppl 1():S119-23.
1989: Goudsmit J; Bakker M; Smit L; Meloen R H
Specificity of chimpanzee antibodies binding a strain-specific HIV-1 neutralization epitope of the external envelope.
Journal of medical primatology 1989;18(3-4):357-62.
1989: van Tijn D A; Boucher C A; Bakker M; Goudsmit J
Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120.
Journal of acquired immune deficiency syndromes 1989;2(3):303-6.
1988: van Griensven G J; de Vroome E M; Tielman R A; Goudsmit J; van der Noordaa J; de Wolf F; Coutinho R A
Impact of HIV antibody testing on changes in sexual behavior among homosexual men in The Netherlands.
American journal of public health 1988;78(12):1575-7.
1988: Miedema F; Petit A J; Terpstra F G; Schattenkerk J K; de Wolf F; Al B J; Roos M; Lange J M; Danner S A; Goudsmit J
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
The Journal of clinical investigation 1988;82(6):1908-14.
1988: De Wolf F; Roos M; Lange J M; Houweling J T; Coutinho R A; van der Noordaa J; Schellekens P T; Goudsmit J
Decline in CD4+ cell numbers reflects increase in HIV-1 replication.
AIDS research and human retroviruses 1988;4(6):433-40.
1988: Geelen J L; Minnaar R P; Boom R; van der Noordaa J; Goudsmit J
Heat-shock induction of the human immunodeficiency virus long terminal repeat.
The Journal of general virology 1988;69 ( Pt 11)():2913-7.
1988: Krone W J; Debouck C; Epstein L G; Heutink P; Meloen R; Goudsmit J
Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo.
Journal of medical virology 1988;26(3):261-70.
1988: Thiriart C; Goudsmit J; Schellekens P; Barin F; Zagury D; De Wilde M; Bruck C
Antibodies to soluble CD4 in HIV-1-infected individuals.
AIDS (London, England) 1988;2(5):345-51.
1988: de Wolf F; Lange J M; Houweling J T; Coutinho R A; Schellekens P T; van der Noordaa J; Goudsmit J
Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.
The Journal of infectious diseases 1988;158(3):615-22.
1988: de Ronde A; Reiss P; Dekker J; de Wolf F; van den Hoek A; Wolfs T; Debouck C; Goudsmit J
Seroconversion to HIV-1 negative regulation factor.
Lancet 1988;2(8610):574.
1988: Goudsmit J; Thiriart C; Smit L; Bruck C; Gibbs C J
Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
Vaccine 1988;6(3):229-32.
1988: Wolfs T F; Breederveld C; Krone W J; vd Hoek L; Bakker M; Smit L; Goudsmit J
HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.
Thrombosis and haemostasis 1988;59(3):396-9.
1988: Goudsmit J; Boucher C A; Meloen R H; Epstein L G; Smit L; van der Hoek L; Bakker M
Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.
AIDS (London, England) 1988;2(3):157-64.
1988: Goudsmit J; Debouck C; Meloen R H; Smit L; Bakker M; Asher D M; Wolff A V; Gibbs C J; Gajdusek D C
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4478-82.
1988: de Gans J; Lange J M; Derix M M; de Wolf F; Eeftinck Schattenkerk J K; Danner S A; Ongerboer de Visser B W; Cload P; Goudsmit J
Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
AIDS (London, England) 1988;2(1):37-40.
1988: Lange J M; Parry J V; de Wolf F; Mortimer P P; Goudsmit J
Diagnostic value of specific IgM antibodies in primary HIV infection.
AIDS (London, England) 1988;2(1):31-5.
1988: de Wolf F; Lange J M; Goudsmit J; Cload P; de Gans J; Schellekens P T; Coutinho R A; Fiddian A P; van der Noordaa J
Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.
Lancet 1988;1(8582):373-6.
1988: Eeftinck Schattenkerk J K; Danner S A; Lange J M; Paul D A; van Boxtel C J; Miedema F; Schellekens P T; Goudsmit J
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.
Archives of internal medicine 1988;148(1):209-11.
1988: Goudsmit J; Ljunggren K; Smit L; Jondal M; Fenyö E M;
Biological significance of the antibody response to HIV antigens expressed on the cell surface.
Archives of virology 1988;103(3-4):189-206.
1988: Boucher C A; de Gans J; van Oers R; Danner S; Goudsmit J
Transmission of HIV and AIDS by plasmapheresis for Guillain-Barré syndrome.
Clinical neurology and neurosurgery 1988;90(3):235-6.
1988: Goudsmit J; Lange J M; Smit L; Bakker M; Klaver B; Danner S A; Coutinho R A
Serodiagnostic profiles of HIV and HIV pathogenesis in vivo.
Haematologia 1988;21(2):71-81.
1988: Goudsmit J
Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.
AIDS (London, England) 1988;2 Suppl 1():S41-5.
1987: Goudsmit J; Paul D A
Circulation of HIV antigen in blood according to stage of infection, risk group, age and geographic origin.
Epidemiology and infection 1987;99(3):701-10.
1987: Goudsmit J; de Wolf F; van de Wiel B; Smit L; Bakker M; Albrecht-van Lent N; Coutinho R A
Spread of human T-cell leukemia virus (HTLV-I) in the Dutch homosexual community.
Journal of medical virology 1987;23(2):115-21.
1987: Lange J M; de Wolf F; Krone W J; Danner S A; Coutinho R A; Goudsmit J
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
AIDS (London, England) 1987;1(3):155-9.
1987: de Wolf F; Goudsmit J; Paul D A; Lange J M; Hooijkaas C; Schellekens P; Coutinho R A; van der Noordaa J
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.
British medical journal (Clinical research ed.) 1987;295(6598):569-72.
1987: Goudsmit J; Lange J M; Krone W J; Teunissen M B; Epstein L G; Danner S A; van den Berg H; Breederveld C; Smit L; Bakker M
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy.
Journal of virological methods 1987;17(1-2):19-34.
1987: van Griensven G J; Tielman R A; Goudsmit J; van der Noordaa J; de Wolf F; de Vroome E M; Coutinho R A
Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands.
American journal of epidemiology 1987;125(6):1048-57.
1987: Goudsmit J; Epstein L G; Paul D A; van der Helm H J; Dawson G J; Asher D M; Yanagihara R; Wolff A V; Gibbs C J; Gajdusek D C
Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(11):3876-80.
1987: Lange J M; Paul D A; de Wolf F; Coutinho R A; Goudsmit J
Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.
AIDS (London, England) 1987;1(1):15-20.
1987: Epstein L G; Goudsmit J; Paul D A; Morrison S H; Connor E M; Oleske J M; Holland B
Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy.
Annals of neurology 1987;21(4):397-401.
1987: Goudsmit J; Smit L; Klaver B; Asher D M; Wolff A; Gibbs C J; Gajdusek D C
Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.
Viral immunology 1987;1(3):225-40.
1987: Goudsmit J; Gibbs C J; Asher D M; Gajdusek D C
Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc 1987;1():509-14.
1986: Lange J M; Paul D A; Huisman H G; de Wolf F; van den Berg H; Coutinho R A; Danner S A; van der Noordaa J; Goudsmit J
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
British medical journal (Clinical research ed.) 1986;293(6560):1459-62.
1986: van Griensven G J; Tielman R A; Goudsmit J; van der Noordaa J; de Wolf F; Coutinho R A
[LAV/HTLV-III infection among a group of homosexual men; prevalence and psychosocial factors]
Nederlands tijdschrift voor geneeskunde 1986;130(48):2178-80.
1986: Goudsmit J; de Wolf F; Paul D A; Epstein L G; Lange J M; Krone W J; Speelman H; Wolters E C; Van der Noordaa J; Oleske J M
Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.
Lancet 1986;2(8500):177-80.
1986: van den Berg W; ten Cate J W; Breederveld C; Goudsmit J
Seroconversion to HTLV-III haemophiliac given heat-treated factor VIII concentrate.
Lancet 1986;1(8484):803-4.
1986: Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
Vox sanguinis 1986;50(1):12-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jaap Goudsmit

Research Profile (preview)

Living Beings

Disorders

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Phenomena

Physiology

Geographic Areas

Activities & Behaviors

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jaap Goudsmit (preview)

All Publications